Top Track 250

This Doncaster group imports and distributes prescription medicines to more than 4,000 independent pharmacies throughout Britain and Ireland. It was formed in 2013, when managing director Mark Gulliford, 50, and finance director Andy Wilson, 54, led a £37m management buyout of DE Group, Doncaster Pharmaceuticals and Eurodrug from wholesaler Mawdsleys. Having dipped in 2017, profits recovered to hit £7.8m last year

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyConverse Pharma
ActivityPharmaceuticals supplier
Sales £m237.9
Operating profit £m7.8
Main shareholdersAndrew Wilson (50%), Mark Gulliford (50%)

If applicable:

* supplied by company   † annualised figure   ‡  profit = ebitda